IRIS
RAMELLA, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.484
EU - Europa 763
NA - Nord America 743
OC - Oceania 14
AF - Africa 13
SA - Sud America 8
Totale 4.025
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.790
US - Stati Uniti d'America 718
CN - Cina 381
IT - Italia 299
HK - Hong Kong 227
GB - Regno Unito 169
DE - Germania 75
NL - Olanda 63
EE - Estonia 57
IN - India 38
FI - Finlandia 29
CA - Canada 22
CZ - Repubblica Ceca 14
AU - Australia 12
TR - Turchia 12
ID - Indonesia 11
UA - Ucraina 11
ZA - Sudafrica 11
FR - Francia 9
RO - Romania 8
AT - Austria 6
BR - Brasile 5
JP - Giappone 4
SE - Svezia 4
TW - Taiwan 4
ES - Italia 3
TH - Thailandia 3
BD - Bangladesh 2
CH - Svizzera 2
IR - Iran 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
VN - Vietnam 1
Totale 4.025
Salva come PNG Salva come JPEG
Città #
Singapore 365
Ashburn 217
Hefei 200
Boardman 195
Hong Kong 161
London 160
Shanghai 137
Rome 124
Amsterdam 38
Los Angeles 30
Council Bluffs 28
Pune 26
San Francisco 25
Seattle 24
Washington 23
Munich 22
Helsinki 19
Toronto 18
Milan 17
Naples 15
Brno 12
Sona 11
Turku 10
West Jordan 10
Hanover 6
Nuremberg 6
Redmond 6
Melbourne 5
Palermo 5
Rocca di Papa 5
Beijing 4
Cascina 4
Florence 4
Frankfurt am Main 4
Haikou 4
Santa Clara 4
Umeå 4
Vicenza 4
Andover 3
Aprilia 3
Bangkok 3
Buffalo 3
Canberra 3
Central 3
Chicago 3
Guangzhou 3
Handan 3
Lucca 3
Markham 3
Sydney 3
São Paulo 3
Turin 3
Vaddangi 3
Vienna 3
Azzano San Paolo 2
Bangalore 2
Banqiao 2
Bari 2
Birmingham 2
Bologna 2
Bratislava 2
Bucharest 2
Cleveland 2
Clifton 2
Dhaka 2
East Orange 2
Genoa 2
Hangzhou 2
Harbin 2
Jakarta 2
Lima 2
Marseille 2
Mexico City 2
Olomouc 2
Osimo 2
Pescara 2
Sant'Anastasia 2
Shenzhen 2
Southall 2
Taipei 2
Tallinn 2
Temecula 2
Tokyo 2
Xi'an 2
Agrate Brianza 1
Almere Stad 1
Auckland 1
Baoding 1
Belgrade 1
Berlin 1
Brescia 1
Brussels 1
Budapest 1
Cairo 1
Cameri 1
Centurion 1
Charlotte 1
Chengdu 1
Chennai 1
Chisinau 1
Totale 2.076
Salva come PNG Salva come JPEG
Nome #
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 86
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 79
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 74
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 66
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 63
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 57
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 49
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 46
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 44
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 42
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 42
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 41
Evaluating GANs in Medical Imaging 41
Exploring Deep Pathomics in Lung Cancer 40
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 39
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 39
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 38
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 38
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 37
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 37
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 37
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 36
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 36
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 36
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 35
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 35
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 35
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 35
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 35
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 34
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 34
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 34
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 34
A deep learning approach for overall survival prediction in lung cancer with missing values 33
Chemoradiation for stage III non-small cell lung cancer 33
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 33
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 32
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 32
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 32
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 32
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 31
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 31
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 31
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 31
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 31
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 31
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 31
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 31
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 30
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 30
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 30
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 30
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 29
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 29
MR imaging of rectal cancer before and after chemoradiation therapy 29
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 28
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 28
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 28
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 28
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 28
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 27
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 27
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 26
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 26
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 26
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 26
Preventing Cardiotoxicity in Personalized Breast Irradiation 25
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 25
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 24
Protective Role of Natural Compounds under Radiation-Induced Injury 24
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 24
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 23
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 22
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 22
Radiation therapy of breast cancer. Reasoned approach to a clinical case 21
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. 21
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 20
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 20
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 19
Radioprotezione 19
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPC 18
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 18
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement 17
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients 17
Radiation Therapy in management of malignant pleural mesothelioma: Pros (2). 17
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives 16
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 16
Bisphosphonates: molecular bases and clinical evidences 16
Breakthrough pain management in patients undergoing radiotherapy: a national survey on behalf of the Palliative and Supportive Care Study Group. 16
Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification 16
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 16
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 15
Dose fractionation and biological optimization in lung cancer 15
Neoadjuvant concurrent chemotherapy and radiotherapy in non-small cell lung cancer 15
Proton beam or photon beam radiotherapy in the treatment of non-small-cell lung cancer 15
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. 15
Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey. 15
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis 15
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 15
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 15
Totale 3.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.921
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 6 6 5 1 3 6 6 13 7 0 168
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024592 21 62 36 35 60 251 14 36 4 22 11 40
2024/20253.147 96 48 221 64 113 219 153 34 522 725 952 0
Totale 4.132